Richard L. Davidson

Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC.

LipimetiX Development LLC operates as a biopharmaceutical company. It develops drugs for the treatment of refractory hypercholesterolemia and hypertriglyceridemia, acute pancreatitis, coronary artery, and peripheral artery diseases by decreasing arterial cholesterol content and inflammation. The company is headquartered in Natick, MA.

Benu BioPharma, Inc. operates a biopharmaceutical development management and consulting company. Its services include development, consulting, product specific services and portfolio triage. The company is headquartered in Natick, MA.

Part of Esperion Therapeutics, Inc., Talaria Therapeutics, Inc. researches and develops technology for treating cardiovascular disease. The company is based in West Conshohocken, PA. Talaria Therapeutics was acquired by Esperion Therapeutics, Inc. on September 30, 2000 for $20.32 million. The company was founded by Dennis I. Goldberg, Chuck G. Hadley.

Part of NB Therapeutics, Nexus Therapeutics, Inc. is a company that provides biopharmaceutical management services. The company is based in Framingham, MA. The CEO of the company is Dennis I. Goldberg. Nexus Therapeutics was acquired by Transport Pharmaceuticals, Inc. on August 14, 2006.

Centre Partners Management LLC (Centre Partners) is a private equity firm founded in 1986 by Lester Pollack. The firm is headquartered in New York with additional offices in Los Angeles.

Cellective BioTherapy, Inc. engages in the research and development of novel cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity, and immunodeficiency. Its proprietary pipeline and technology platform focuses on the unique aspects of B cell biology that are involved in regulating a variety of autoimmune diseases and inflammatory immune responses. The company was founded by Thomas F. Tedder in 2015 and is headquartered in Durham, NC.

Deep Blue Medical Advances, Inc. operates as a biotechnology firm. It offers t-line mesh and anchor clips solutions. The company was founded by Howard Levinson and Ken Gall in March 2015 and is headquartered in Durham, NC.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Wilmer Cutler Pickering Hale & Dorr LLP provides legal services. It specializes in trial, appellate, securities, regulatory, intellectual property, corporate transactions, bankruptcy, environmental, labor and employment, private client, real estate and tax matters. The company was founded in 1918 and is headquartered in Boston, MA.

K2 Pure Solutions, Inc. manufactures personal care and household cleaning products. It provides mitigate the potential environmental, security and operational risks associated with the transport of chlorine for water treatment and other industries by producing exceptionally pure bleach, caustic soda and other chlor-alkali related products using only salt, water and electricity in the most economically viable manner. The company was founded by David Cynamon and Howard Brodie and is headquartered in Toronto, Canada.

AspenTree Capital Corp. provides investment advice. The private company is based in Durham, NC.

NeurOp, Inc. manufactures and distributes pharmaceutical products. It operates as a biopharmaceutical company which develops new medicines for central nervous system disorders, including depression, neuropathic pain, ischemia, schizophrenia, and alzheimer's and parkinson's diseases. The company was founded by Raymond Dingledine, James McNamara and Stephen Traynelis in 2002 and is headquartered in Atlanta, GA.

InnAVasc Medical, Inc. designs and develops products for vascular access for hemodialysis. Its technology vascular access graft is designed to create one contiguous flow lumen without transition points. The company is headquartered in Durham, NC.

eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA.